Literature DB >> 21115567

Dose response biology: the case of resveratrol.

Edward J Calabrese1, Mark P Mattson, Vittorio Calabrese.   

Abstract

Resveratrol often displays hormesis-like biphasic dose responses. This occurs in a broad range of biological models and for numerous endpoints of biomedical interest and public health concern. Recognition of the widespread occurrence of the hormetic nature of many of the responses of resveratrol is important on multiple levels. It can help optimize study design protocols by investigators, create a dose-response framework for better addressing dose-related biological complexities and assist in the development of public health and medical guidance with respect to considerations for what is an optimal dose not just for an agent such as resveratrol, but also for the plethora of agents that also act via hormetic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115567     DOI: 10.1177/0960327110383641

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  11 in total

1.  Dose response biology of resveratrol in obesity.

Authors:  Giovanni Scapagnini; Sergio Davinelli; Taku Kaneko; Guido Koverech; Angela Koverech; Edward J Calabrese; Vittorio Calabrese
Journal:  J Cell Commun Signal       Date:  2014-11-12       Impact factor: 5.782

2.  Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra.

Authors:  Adrian C Williams; Lisa J Hill; David B Ramsden
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-21

3.  Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice.

Authors:  Naïg Gueguen; Valérie Desquiret-Dumas; Géraldine Leman; Stéphanie Chupin; Stéphanie Baron; Valérie Nivet-Antoine; Emilie Vessières; Audrey Ayer; Daniel Henrion; Guy Lenaers; Pascal Reynier; Vincent Procaccio
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

Review 4.  Hormesis in aging and neurodegeneration-a prodigy awaiting dissection.

Authors:  Lei Mao; Jacqueline Franke
Journal:  Int J Mol Sci       Date:  2013-06-25       Impact factor: 5.923

Review 5.  Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling.

Authors:  Carolin Cornelius; Guido Koverech; Rosalia Crupi; Rosanna Di Paola; Angela Koverech; Francesca Lodato; Maria Scuto; Angela T Salinaro; Salvatore Cuzzocrea; Edward J Calabrese; Vittorio Calabrese
Journal:  Front Pharmacol       Date:  2014-06-10       Impact factor: 5.810

6.  High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation.

Authors:  Dariusz Szukiewicz; Michal Pyzlak; Grzegorz Szewczyk; Aleksandra Stangret; Seweryn Trojanowski; Michal Bachanek; Wojciech Braksator; Jaroslaw Wejman
Journal:  Mediators Inflamm       Date:  2017-06-01       Impact factor: 4.711

Review 7.  Mediterranean diet and inflammaging within the hormesis paradigm.

Authors:  Morena Martucci; Rita Ostan; Fiammetta Biondi; Elena Bellavista; Cristina Fabbri; Claudia Bertarelli; Stefano Salvioli; Miriam Capri; Claudio Franceschi; Aurelia Santoro
Journal:  Nutr Rev       Date:  2017-06-01       Impact factor: 7.110

8.  Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages.

Authors:  Anne Marie Allen; Annette Graham
Journal:  Lipids Health Dis       Date:  2012-12-10       Impact factor: 3.876

9.  Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: Mitochondria as a "chi".

Authors:  Carolin Cornelius; Rosario Perrotta; Antonio Graziano; Edward J Calabrese; Vittorio Calabrese
Journal:  Immun Ageing       Date:  2013-04-25       Impact factor: 6.400

10.  Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S‑phase cell cycle arrest and apoptosis through caspase/cyclin‑CDK pathways.

Authors:  Bin Liu; Zhongyou Zhou; Wei Zhou; Jie Liu; Qingyu Zhang; Juan Xia; Juntao Liu; Nianping Chen; Mingyi Li; Runzhi Zhu
Journal:  Mol Med Rep       Date:  2014-07-21       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.